TreeWAS – Variant ID: rs1809529

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.582	0.418	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.569	0.431	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.555	0.445	0.000
T42.4 Benzodiazepines	0.537	0.463	0.000
T45.0 Antiallergic and antiemetic drugs	0.536	0.464	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.528	0.472	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.523	0.477	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.519	0.481	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.518	0.482	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.517	0.483	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.498	0.502	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.489	0.511	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.482	0.518	0.000
T40.2 Other opioids	0.480	0.520	0.000
T43.2 Other and unspecified antidepressants	0.474	0.526	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.464	0.536	0.000
T42.0 Hydantoin derivatives	0.463	0.537	0.000
T36 Poisoning by systemic antibiotics	0.460	0.540	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.450	0.550	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.440	0.560	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.436	0.564	0.000
T45.5 Anticoagulants	0.425	0.575	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.422	0.578	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.422	0.578	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.421	0.579	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.418	0.582	0.000
T48.5 Anti-common-cold drugs	0.416	0.584	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.410	0.590	0.000
T40.5 Cocaine	0.409	0.591	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.408	0.592	0.000
T45.8 Other primarily systemic and haematological agents	0.408	0.592	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.408	0.592	0.000
T45.6 Fibrinolysis-affecting drugs	0.408	0.592	0.000
T45.4 Iron and its compounds	0.408	0.592	0.000
T45.3 Enzymes, not elsewhere classified	0.408	0.592	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.408	0.592	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.400	0.600	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.398	0.602	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.398	0.602	0.000
T42.3 Barbiturates	0.398	0.602	0.000
T42.2 Succinimides and oxazolidinediones	0.398	0.602	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.397	0.603	0.000
T45.2 Vitamins, not elsewhere classified	0.397	0.603	0.000
T42.1 Iminostilbenes	0.396	0.604	0.000
T40.6 Other and unspecified narcotics	0.396	0.604	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.394	0.606	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.388	0.612	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.379	0.621	0.000
T46.7 Peripheral vasodilators	0.379	0.621	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.379	0.621	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.377	0.623	0.000
T46.1 Calcium-channel blockers	0.376	0.624	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.375	0.625	0.000
T40.8 Lysergide [LSD]	0.375	0.625	0.000
T40.7 Cannabis (derivatives)	0.375	0.625	0.000
T40.3 Methadone	0.375	0.625	0.000
T40.1 Heroin	0.375	0.625	0.000
T40.0 Opium	0.375	0.625	0.000
T43.9 Psychotropic drug, unspecified	0.372	0.628	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.372	0.628	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.372	0.628	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.372	0.628	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.371	0.629	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.371	0.629	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.371	0.629	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.371	0.629	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.371	0.629	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.371	0.629	0.000
T44.0 Anticholinesterase agents	0.371	0.629	0.000
T36.4 Tetracyclines	0.363	0.637	0.000
T38.1 Thyroid hormones and substitutes	0.362	0.638	0.000
T38.0 Glucocorticoids and synthetic analogues	0.358	0.642	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.357	0.643	0.000
T48.4 Expectorants	0.357	0.643	0.000
T48.3 Antitussives	0.357	0.643	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.357	0.643	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.357	0.643	0.000
T48.0 Oxytocic drugs	0.357	0.643	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.353	0.647	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.352	0.648	0.000
T49.9 Topical agent, unspecified	0.351	0.649	0.000
T49.8 Other topical agents	0.351	0.649	0.000
T49.7 Dental drugs, topically applied	0.351	0.649	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.351	0.649	0.000
T49.5 Ophthalmological drugs and preparations	0.351	0.649	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.351	0.649	0.000
T49.3 Emollients, demulcents and protectants	0.351	0.649	0.000
T49.2 Local astringents and local detergents	0.351	0.649	0.000
T49.1 Antipruritics	0.351	0.649	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.345	0.654	0.000
T36.0 Penicillins	0.343	0.657	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.343	0.657	0.000
T38.9 Other and unspecified hormone antagonists	0.333	0.667	0.000
T38.7 Androgens and anabolic congeners	0.333	0.667	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.333	0.667	0.000
T38.5 Other oestrogens and progestogens	0.333	0.667	0.000
T38.4 Oral contraceptives	0.333	0.667	0.000
T38.2 Antithyroid drugs	0.333	0.667	0.000
T36.9 Systemic antibiotic, unspecified	0.330	0.670	0.000
T36.8 Other systemic antibiotics	0.330	0.670	0.000
T36.7 Antifungal antibiotics, systemically used	0.330	0.670	0.000
T36.6 Rifamycins	0.330	0.670	0.000
T36.5 Aminoglycosides	0.330	0.670	0.000
T36.3 Macrolides	0.330	0.670	0.000
T36.2 Chloramphenicol group	0.330	0.670	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.330	0.670	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.319	0.681	0.000
T40.4 Other synthetic narcotics	0.302	0.698	0.000
T41.5 Therapeutic gases	0.299	0.700	0.000
T41.4 Anaesthetic, unspecified	0.299	0.700	0.000
T41.3 Local anaesthetics	0.299	0.700	0.000
T41.2 Other and unspecified general anaesthetics	0.299	0.700	0.000
T41.1 Intravenous anaesthetics	0.299	0.700	0.000
T41.0 Inhaled anaesthetics	0.299	0.700	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.298	0.702	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.297	0.703	0.000
T47.0 Histamine H(2)-receptor antagonists	0.295	0.705	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.294	0.706	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.294	0.706	0.000
T47.7 Emetics	0.294	0.706	0.000
T47.6 Antidiarrhoeal drugs	0.294	0.706	0.000
T47.5 Digestants	0.294	0.706	0.000
T47.4 Other laxatives	0.294	0.706	0.000
T47.3 Saline and osmotic laxatives	0.294	0.706	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.292	0.707	0.000
T37.5 Antiviral drugs	0.292	0.707	0.000
T37.4 Anthelminthics	0.292	0.707	0.000
T37.3 Other antiprotozoal drugs	0.292	0.707	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.292	0.707	0.000
T37.1 Antimycobacterial drugs	0.292	0.707	0.000
T37.0 Sulphonamides	0.292	0.707	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.287	0.713	0.000
T50.8 Diagnostic agents	0.284	0.716	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.282	0.717	0.000
T43.6 Psychostimulants with abuse potential	0.282	0.718	0.000
T47.2 Stimulant laxatives	0.280	0.719	0.000
T50.7 Analeptics and opioid receptor antagonists	0.278	0.722	0.000
T50.5 Appetite depressants	0.278	0.722	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.278	0.722	0.000
T50.1 Loop [high-ceiling] diuretics	0.278	0.722	0.000
T50.0 Mineralocorticoids and their antagonists	0.278	0.722	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.272	0.728	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.256	0.744	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.255	0.745	0.000
T50.4 Drugs affecting uric acid metabolism	0.250	0.750	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.250	0.750	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.231	0.768	0.000
T39.4 Antirheumatics, not elsewhere classified	0.206	0.794	0.000
T39.2 Pyrazolone derivatives	0.206	0.794	0.000
T39.0 Salicylates	0.200	0.800	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.198	0.802	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.193	0.807	0.000
T39.1 4-Aminophenol derivatives	0.148	0.852	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.133	0.867	0.000
C25 Malignant neoplasm of pancreas	0.051	0.949	0.000
C25.0 Head of pancreas	0.049	0.951	0.000
C25.2 Tail of pancreas	0.049	0.951	0.000
C25.4 Endocrine pancreas	0.045	0.955	0.000
C25.1 Body of pancreas	0.044	0.956	0.000
C25.7 Other parts of pancreas	0.043	0.957	0.000
C25.3 Pancreatic duct	0.042	0.957	0.000
C25.8 Overlapping lesion of pancreas	0.041	0.959	0.000
C25.9 Pancreas, unspecified	0.037	0.963	0.000
H72 Perforation of tympanic membrane	0.025	0.975	0.000
N93.0 Postcoital and contact bleeding	0.000	0.976	0.024
H72.2 Other marginal perforations of tympanic membrane	0.019	0.981	0.000
E27.1 Primary adrenocortical insufficiency	0.017	0.983	0.000
E27 Other disorders of adrenal gland	0.017	0.983	0.000
E29.1 Testicular hypofunction	0.016	0.984	0.000
H72.8 Other perforations of tympanic membrane	0.016	0.984	0.000
E29 Testicular dysfunction	0.015	0.985	0.000
E27.2 Addisonian crisis	0.014	0.986	0.000
E23 Hypofunction and other disorders of pituitary gland	0.014	0.986	0.000
E20-E35 Disorders of other endocrine glands	0.014	0.986	0.000
E23.0 Hypopituitarism	0.014	0.986	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.014	0.986	0.000
H72.1 Attic perforation of tympanic membrane	0.013	0.986	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.013	0.987	0.000
E27.8 Other specified disorders of adrenal gland	0.013	0.987	0.000
E23.7 Disorder of pituitary gland, unspecified	0.012	0.988	0.000
E27.5 Adrenomedullary hyperfunction	0.012	0.988	0.000
E27.0 Other adrenocortical overactivity	0.012	0.988	0.000
E34 Other endocrine disorders	0.011	0.989	0.000
E23.2 Diabetes insipidus	0.011	0.989	0.000
E29.9 Testicular dysfunction, unspecified	0.011	0.989	0.000
E29.8 Other testicular dysfunction	0.011	0.989	0.000
E29.0 Testicular hyperfunction	0.011	0.989	0.000
E31 Polyglandular dysfunction	0.011	0.989	0.000
E24 Cushing's syndrome	0.010	0.989	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.010	0.990	0.000
E23.1 Drug-induced hypopituitarism	0.010	0.990	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.010	0.990	0.000
E32 Diseases of thymus	0.010	0.990	0.000
E30 Disorders of puberty, not elsewhere classified	0.010	0.990	0.000
E25 Adrenogenital disorders	0.010	0.990	0.000
E20 Hypoparathyroidism	0.010	0.990	0.000
E27.9 Disorder of adrenal gland, unspecified	0.009	0.991	0.000
E26 Hyperaldosteronism	0.009	0.991	0.000
E22 Hyperfunction of pituitary gland	0.009	0.991	0.000
E34.8 Other specified endocrine disorders	0.009	0.991	0.000
E24.9 Cushing's syndrome, unspecified	0.008	0.991	0.000
E23.6 Other disorders of pituitary gland	0.008	0.991	0.000
E34.3 Short stature, not elsewhere classified	0.008	0.992	0.000
E31.0 Autoimmune polyglandular failure	0.008	0.992	0.000
E34.5 Androgen resistance syndrome	0.008	0.992	0.000
E34.4 Constitutional tall stature	0.008	0.992	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.008	0.992	0.000
E34.1 Other hypersecretion of intestinal hormones	0.008	0.992	0.000
E28 Ovarian dysfunction	0.008	0.992	0.000
E34.9 Endocrine disorder, unspecified	0.008	0.992	0.000
E31.9 Polyglandular dysfunction, unspecified	0.008	0.992	0.000
E31.8 Other polyglandular dysfunction	0.008	0.992	0.000
E31.1 Polyglandular hyperfunction	0.008	0.992	0.000
E24.8 Other Cushing's syndrome	0.008	0.992	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.008	0.992	0.000
E24.3 Ectopic ACTH syndrome	0.008	0.992	0.000
E24.1 Nelson's syndrome	0.008	0.992	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.000	0.992	0.008
E30.9 Disorder of puberty, unspecified	0.008	0.992	0.000
E30.8 Other disorders of puberty	0.008	0.992	0.000
E30.1 Precocious puberty	0.008	0.992	0.000
E30.0 Delayed puberty	0.008	0.992	0.000
E32.9 Disease of thymus, unspecified	0.008	0.992	0.000
E32.8 Other diseases of thymus	0.008	0.992	0.000
E32.1 Abscess of thymus	0.008	0.992	0.000
E32.0 Persistent hyperplasia of thymus	0.008	0.992	0.000
E34.0 Carcinoid syndrome	0.008	0.992	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.008	0.992	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.008	0.992	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.008	0.992	0.000
E24.2 Drug-induced Cushing's syndrome	0.008	0.992	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.000	0.992	0.008
E25.9 Adrenogenital disorder, unspecified	0.007	0.992	0.000
E25.8 Other adrenogenital disorders	0.007	0.992	0.000
C02.1 Border of tongue	0.000	0.992	0.008
C01 Malignant neoplasm of base of tongue	0.000	0.992	0.008
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.007	0.993	0.000
E20.8 Other hypoparathyroidism	0.007	0.993	0.000
E20.1 Pseudohypoparathyroidism	0.007	0.993	0.000
E20.0 Idiopathic hypoparathyroidism	0.007	0.993	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.000	0.993	0.007
E24.0 Pituitary-dependent Cushing's disease	0.007	0.993	0.000
C10 Malignant neoplasm of oropharynx	0.000	0.993	0.007
C12 Malignant neoplasm of pyriform sinus	0.000	0.993	0.007
E26.9 Hyperaldosteronism, unspecified	0.007	0.993	0.000
H72.0 Central perforation of tympanic membrane	0.007	0.993	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.007	0.993	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.007	0.993	0.000
C14.0 Pharynx, unspecified	0.000	0.993	0.007
E26.8 Other hyperaldosteronism	0.007	0.993	0.000
E26.1 Secondary hyperaldosteronism	0.007	0.993	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.007	0.993	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.007	0.993	0.000
C10.9 Oropharynx, unspecified	0.000	0.993	0.007
C05 Malignant neoplasm of palate	0.000	0.993	0.007
E22.8 Other hyperfunction of pituitary gland	0.007	0.993	0.000
I85.9 Oesophageal varices without bleeding	0.000	0.993	0.007
E20.9 Hypoparathyroidism, unspecified	0.006	0.993	0.000
Y83.9 Surgical procedure, unspecified	0.006	0.994	0.000
C02.9 Tongue, unspecified	0.000	0.994	0.006
N48.8 Other specified disorders of penis	0.000	0.994	0.006
C03 Malignant neoplasm of gum	0.000	0.994	0.006
C11 Malignant neoplasm of nasopharynx	0.000	0.994	0.006
C05.1 Soft palate	0.000	0.994	0.006
E28.9 Ovarian dysfunction, unspecified	0.006	0.994	0.000
E28.8 Other ovarian dysfunction	0.006	0.994	0.000
E28.1 Androgen excess	0.006	0.994	0.000
E28.0 Oestrogen excess	0.006	0.994	0.000
K59.3 Megacolon, not elsewhere classified	0.006	0.994	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.006	0.994	0.000
E22.1 Hyperprolactinaemia	0.006	0.994	0.000
C09 Malignant neoplasm of tonsil	0.000	0.994	0.006
C00 Malignant neoplasm of lip	0.000	0.994	0.006
C02.2 Ventral surface of tongue	0.000	0.994	0.006
C08 Malignant neoplasm of other and unspecified major salivary glands	0.000	0.994	0.006
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.006	0.994	0.000
C02.8 Overlapping lesion of tongue	0.000	0.994	0.006
C02.3 Anterior two-thirds of tongue, part unspecified	0.000	0.994	0.006
C02.0 Dorsal surface of tongue	0.000	0.994	0.006
E26.0 Primary hyperaldosteronism	0.005	0.994	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.000	0.995	0.005
C14.2 Waldeyer's ring	0.000	0.995	0.005
E22.0 Acromegaly and pituitary gigantism	0.005	0.995	0.000
E28.3 Primary ovarian failure	0.005	0.995	0.000
C10.8 Overlapping lesion of oropharynx	0.000	0.995	0.005
C10.4 Branchial cleft	0.000	0.995	0.005
C10.3 Posterior wall of oropharynx	0.000	0.995	0.005
C10.2 Lateral wall of oropharynx	0.000	0.995	0.005
C10.1 Anterior surface of epiglottis	0.000	0.995	0.005
C10.0 Vallecula	0.000	0.995	0.005
C02.4 Lingual tonsil	0.000	0.995	0.005
C07 Malignant neoplasm of parotid gland	0.000	0.995	0.005
C13 Malignant neoplasm of hypopharynx	0.000	0.995	0.005
C04 Malignant neoplasm of floor of mouth	0.000	0.995	0.005
E21.2 Other hyperparathyroidism	0.005	0.995	0.000
K31.4 Gastric diverticulum	0.005	0.995	0.000
E21.4 Other specified disorders of parathyroid gland	0.005	0.995	0.000
C05.9 Palate, unspecified	0.000	0.995	0.005
C05.8 Overlapping lesion of palate	0.000	0.995	0.005
C05.2 Uvula	0.000	0.995	0.005
C05.0 Hard palate	0.000	0.995	0.005
C03.1 Lower gum	0.000	0.995	0.005
C11.9 Nasopharynx, unspecified	0.000	0.995	0.005
G00.1 Pneumococcal meningitis	0.000	0.995	0.005
C09.9 Tonsil, unspecified	0.000	0.995	0.005
C08.0 Submandibular gland	0.000	0.995	0.005
C00.0 External upper lip	0.000	0.995	0.005
G00 Bacterial meningitis, not elsewhere classified	0.000	0.995	0.005
C03.9 Gum, unspecified	0.000	0.995	0.004
C03.0 Upper gum	0.000	0.995	0.004
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.000	0.995	0.005
C11.8 Overlapping lesion of nasopharynx	0.000	0.995	0.004
C11.3 Anterior wall of nasopharynx	0.000	0.995	0.004
C11.2 Lateral wall of nasopharynx	0.000	0.995	0.004
C11.1 Posterior wall of nasopharynx	0.000	0.995	0.004
C11.0 Superior wall of nasopharynx	0.000	0.995	0.004
C06 Malignant neoplasm of other and unspecified parts of mouth	0.000	0.995	0.004
C09.8 Overlapping lesion of tonsil	0.000	0.995	0.004
C09.0 Tonsillar fossa	0.000	0.995	0.004
C00.8 Overlapping lesion of lip	0.000	0.995	0.004
C00.6 Commissure of lip	0.000	0.995	0.004
C00.5 Lip, unspecified, inner aspect	0.000	0.995	0.004
C00.4 Lower lip, inner aspect	0.000	0.995	0.004
C00.3 Upper lip, inner aspect	0.000	0.995	0.004
C00.2 External lip, unspecified	0.000	0.995	0.004
C00.1 External lower lip	0.000	0.995	0.004
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.000	0.995	0.004
G00-G09 Inflammatory diseases of the central nervous system	0.000	0.996	0.004
C08.8 Overlapping lesion of major salivary glands	0.000	0.996	0.004
C08.1 Sublingual gland	0.000	0.996	0.004
E28.2 Polycystic ovarian syndrome	0.004	0.996	0.000
C00.9 Lip, unspecified	0.000	0.996	0.004
C09.1 Tonsillar pillar (anterior) (posterior)	0.000	0.996	0.004
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.000	0.996	0.004
I85 Oesophageal varices	0.000	0.996	0.004
G00.9 Bacterial meningitis, unspecified	0.000	0.996	0.004
C04.0 Anterior floor of mouth	0.000	0.996	0.004
I85.0 Oesophageal varices with bleeding	0.000	0.996	0.004
C13.8 Overlapping lesion of hypopharynx	0.000	0.996	0.004
C13.2 Posterior wall of hypopharynx	0.000	0.996	0.004
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.000	0.996	0.004
C08.9 Major salivary gland, unspecified	0.000	0.996	0.004
C04.8 Overlapping lesion of floor of mouth	0.000	0.996	0.004
C04.1 Lateral floor of mouth	0.000	0.996	0.004
C13.9 Hypopharynx, unspecified	0.000	0.996	0.004
D33.3 Cranial nerves	0.000	0.996	0.004
G01 Meningitis in bacterial diseases classified elsewhere	0.000	0.996	0.004
H05.0 Acute inflammation of orbit	0.000	0.996	0.004
G03 Meningitis due to other and unspecified causes	0.000	0.996	0.004
G00.8 Other bacterial meningitis	0.000	0.996	0.004
G00.3 Staphylococcal meningitis	0.000	0.996	0.004
G00.2 Streptococcal meningitis	0.000	0.996	0.004
G00.0 Haemophilus meningitis	0.000	0.996	0.004
G06 Intracranial and intraspinal abscess and granuloma	0.000	0.996	0.004
G09 Sequelae of inflammatory diseases of central nervous system	0.000	0.996	0.004
C13.0 Postcricoid region	0.000	0.996	0.003
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.000	0.996	0.003
C06.1 Vestibule of mouth	0.000	0.996	0.003
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.000	0.996	0.003
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.000	0.996	0.003
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.000	0.996	0.003
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.000	0.997	0.003
X62.9 Unspecified place	0.003	0.997	0.000
C06.2 Retromolar area	0.000	0.997	0.003
X63.0 Home	0.003	0.997	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.000	0.997	0.003
M25.86 Other specified joint disorders (Lower leg)	0.000	0.997	0.003
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
M19.01 Primary arthrosis of other joints (Shoulder region)	0.003	0.997	0.000
C04.9 Floor of mouth, unspecified	0.000	0.997	0.003
G03.9 Meningitis, unspecified	0.000	0.997	0.003
G06.2 Extradural and subdural abscess, unspecified	0.000	0.997	0.003
C06.9 Mouth, unspecified	0.000	0.997	0.003
C06.0 Cheek mucosa	0.000	0.997	0.003
C71.3 Parietal lobe	0.003	0.997	0.000
G03.8 Meningitis due to other specified causes	0.000	0.997	0.003
G03.2 Benign recurrent meningitis [Mollaret]	0.000	0.997	0.003
G03.1 Chronic meningitis	0.000	0.997	0.003
G03.0 Nonpyogenic meningitis	0.000	0.997	0.003
G06.0 Intracranial abscess and granuloma	0.000	0.997	0.003
T92.1 Sequelae of fracture of arm	0.000	0.997	0.003
I86.1 Scrotal varices	0.000	0.997	0.003
C71.9 Brain, unspecified	0.003	0.997	0.000
E21.3 Hyperparathyroidism, unspecified	0.003	0.997	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.003	0.997	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.003	0.997	0.000
K86.8 Other specified diseases of pancreas	0.003	0.997	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.997	0.003
G06.1 Intraspinal abscess and granuloma	0.000	0.997	0.003
C71 Malignant neoplasm of brain	0.003	0.997	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.000	0.997	0.002
G04.1 Tropical spastic paraplegia	0.000	0.997	0.002
G04.0 Acute disseminated encephalitis	0.000	0.997	0.002
S09.9 Unspecified injury of head	0.003	0.997	0.000
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.000	0.997	0.002
G02.1 Meningitis in mycoses	0.000	0.997	0.002
C71.0 Cerebrum, except lobes and ventricles	0.003	0.997	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.000	0.997	0.003
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot	0.003	0.997	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.000	0.997	0.002
C71.4 Occipital lobe	0.002	0.997	0.000
B00.9 Herpesviral infection, unspecified	0.000	0.998	0.002
E04.9 Non-toxic goitre, unspecified	0.002	0.998	0.000
D07.5 Prostate	0.002	0.998	0.000
G02.0 Meningitis in viral diseases classified elsewhere	0.000	0.998	0.002
X60-X84 Intentional self-harm	0.002	0.998	0.000
H57.1 Ocular pain	0.000	0.998	0.002
L71.9 Rosacea, unspecified	0.002	0.998	0.000
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
X62.0 Home	0.002	0.998	0.000
X62.8 Other specified place	0.002	0.998	0.000
X62.7 Farm	0.002	0.998	0.000
X62.6 Industrial and construction area	0.002	0.998	0.000
X62.5 Trade and service area	0.002	0.998	0.000
X62.4 Street and highway	0.002	0.998	0.000
X62.3 Sports and athletics area	0.002	0.998	0.000
X62.2 School, other institution and public administrative area	0.002	0.998	0.000
X62.1 Residential institution	0.002	0.998	0.000
N93 Other abnormal uterine and vaginal bleeding	0.000	0.998	0.002
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.000	0.998	0.002
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
Q43.9 Congenital malformation of intestine, unspecified	0.002	0.998	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.998	0.002
Q54.9 Hypospadias, unspecified	0.002	0.998	0.000
X69.0 Home	0.002	0.998	0.000
G54.0 Brachial plexus disorders	0.000	0.998	0.002
C71.7 Brain stem	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.998	0.002
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
Q38.7 Pharyngeal pouch	0.002	0.998	0.000
Q54.0 Hypospadias, balanic	0.002	0.998	0.000
Q76.0 Spina bifida occulta	0.002	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
B37.0 Candidal stomatitis	0.000	0.998	0.002
Q98.4 Klinefelter's syndrome, unspecified	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
X69.9 Unspecified place	0.002	0.998	0.000
S09.8 Other specified injuries of head	0.002	0.998	0.000
Q54 Hypospadias	0.002	0.998	0.000
R68.8 Other specified general symptoms and signs	0.002	0.998	0.000
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
S92.3 Fracture of metatarsal bone	0.000	0.998	0.002
S93.1 Dislocation of toe(s)	0.000	0.998	0.002
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.002	0.998	0.000
R20.2 Paraesthesia of skin	0.002	0.998	0.000
X69.8 Other specified place	0.002	0.998	0.000
X69.7 Farm	0.002	0.998	0.000
X69.6 Industrial and construction area	0.002	0.998	0.000
X69.5 Trade and service area	0.002	0.998	0.000
X69.4 Street and highway	0.002	0.998	0.000
X69.3 Sports and athletics area	0.002	0.998	0.000
X69.2 School, other institution and public administrative area	0.002	0.998	0.000
X69.1 Residential institution	0.002	0.998	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.002	0.998	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
F50.2 Bulimia nervosa	0.002	0.998	0.000
R41.2 Retrograde amnesia	0.002	0.998	0.000
X70.2 School, other institution and public administrative area	0.002	0.998	0.000
S09 Other and unspecified injuries of head	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.000	0.998	0.002
T02.40 Fractures involving multiple regions of both upper limbs (closed)	0.000	0.998	0.002
Y83.4 Other reconstructive surgery	0.002	0.998	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
C70.0 Cerebral meninges	0.002	0.998	0.000
S92.10 Fracture of talus (closed)	0.000	0.998	0.002
Q54.1 Hypospadias, penile	0.002	0.998	0.000
X60.9 Unspecified place	0.002	0.998	0.000
X60.0 Home	0.002	0.998	0.000
X60.7 Farm	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations